Seeing is believing. We have evolved with a reliance on our visual system to understand the world around us. This is evident in the vital role of imaging in major discoveries in medicine and biological sciences throughout the past few centuries. But have we reached the limit of what we can learn from simple visual inspection of images? The human eye and brain are good at recognizing patterns, but not as adept at detecting subtle differences in intensity. As we move into an era of big data and high-content experiments, there is also a limit to how many images can be reliably assessed manually in a defined timeframe. Enter quantitative imaging, where the focus is on removing the tedious aspects of imaging and image analysis, enabling scientists to devote time and energy toward using these techniques to answer important biological and medical questions.
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Quantitative imaging also addresses a key issue of reproducibility in life sciences research. Selected representative images are no longer considered adequate proof of a discovery, because these run the risk of observer bias. The development of algorithms to quantify images has transformed the way microscopic and macroscopic imaging studies are performed and reported, by allowing assessment and quantification from a larger set of samples. Enabling these advances for the use of imaging in medicine and life sciences research requires technological advances in several fields. The quantitative imaging revolution affects multiple steps of the experimental process, requiring advances in technology to facilitate imaging, capture high-content images, and analyze them. In this special issue, SLAS Technology shares examples of studies that provide novel insight into different steps of the quantitative imaging process.
Mella et al. 1 report the development of a novel imagingbased biosensor for high-throughput assays of G protein-coupled receptor (GPCR) signaling, with a specific focus on discriminating Ca+-mediated and cyclic adenosine monophosphate (cAMP)-mediated signaling. This is an advance in development of biological tools that aid the process of screening, which may aid the identification of novel GPCR ligands and regulators of signaling in this clinically relevant set of targets. Li et al. 2 focus on the nature of cell culture systems used in high-throughput imaging assays and the development of a novel co-culture system of immortalized endothelial and mesenchymal cell lines to evaluate angiogenesis. Such a system allows the evaluation of compounds that may influence angiogenesis, a key process in development and cancer. Lee et al. 3 take the step of developing robust cell culture systems a step further by addressing the issue of high-throughput screening in three-dimensional (3D) cell culture. The behavior of cells in two-dimensional (2D) cell cultures is known to be different from that in 3D cell culture, which is ostensibly a closer reflection of 3D multicellular organisms. They describe the differences in cell viability screening using 2D and 3D cell culture systems, suggesting a higher accuracy of measurements in 3D culture systems. Given the notoriously poor correlation between in vitro findings and in vivo findings for cytostatic and cytotoxic drugs in oncology, such advances are likely to help bridge the bench-to-bedside gap. Leary et al. 4 further address this issue by describing ratiometric fluorescent assays of a nuclear dye that can be measured by confocal imaging to enable screening approaches and biological experiments in 3D cell culture systems. Although single stains are advantageous in their simplicity, they may not capture adequate information in a high-throughput imaging screening assay or experiment. Rose et al. 5 share a combination of unrelated cellular stains that can be used in quantitative microscopy experiments to facilitate drug screening by increasing the number of composite cellular outcomes that are measured.
The proof in the pudding, when it comes to translational research, lies in the ability to quantitatively assess images that are obtained from human samples of disease and health. Ng et al. 6 describe a novel assay to quantitate markers of follicular T-helper cells, within a T-cell lymphoma, using a digital pathology platform. This allows the identification of angio-immunoblastic T-cell lymphoma, a T-lymphoma subtype that is challenging to diagnose for inexperienced histopathologists and has potential clinical diagnostic applicability. Beyond microscopic imaging, quantitation in medicine is vital for radiological images. Wang et al. 7 describe a marker-free 3D tool based on diffusion-weighted magnetic resonance imaging (MRI) to discriminate healthy from fibrotic livers in humans. Quantitative approaches with incorporation of artificial intelligence tools are likely to transform the use of radiological imaging in clinical practice. All imaging-based approaches, however, suffer from a common fallacy of instrumental noise. In this issue, Sengottuvel et al. 8 consider a mathematical formulation for the extraction of noise from electrogastrogram signals, which can be conceptualized in imaging studies as well. Finally, Zavaleta et al. 9 provide a review of the use of theranostic nanoparticles that can be used in a variety of quantifiable diagnostic approaches for human disease.
As the guest editor of this special issue, I would like to thank all the scientists who contributed their insight and experience to this compilation, and those who helped with the peer review and editorial process. We hope this issue provides a meaningful glimpse into the potential and applicability of quantitative imaging in the life sciences and biomedical research.
